Home » Newsletters » BioWorld

BioWorld

Dec. 23, 1994

View Archived Issues

XOMA DISCONTINUES DEVELOPMENT OF CD5 PLUS

GLYCOMED'S PHASE II/III RESULTS OF GALARDIN ARE POSITIVE

AMGEN'S NEUPOGEN APPROVED FOR SEVERE CHRONIC NEUTROPENIA

SCHERER `DEMANDS' ACCESS TO PROCYTE'S SHAREHOLDER LIST

PTO TELLS ITS EXAMINERS TO ACCEPT `CREDIBLE' CLAIMS

PHARMACOPEIA SIGNS POTENTIAL $75M DEAL WITH SCHERING-PLOUGH

CENTOCOR GIVES BIOTECH A BOOST WITH FDA APPROVAL OF REOPRO